William J. Barson, MD :: Nationwide Children’s Hospital, Columbus, Ohio

William J. Barson, MD

William J. Barson, MD Best Doctors 2011-2012

Hospital-Based Research Faculty
Principal Investigator

Infectious Diseases
Section Chief

Infectious Diseases Fellowship
Program Director

Contact Information

Infectious Diseases
700 Children's Dr
Columbus, OH 43205 [ map ]
PH: (614) 722-4864
FX: (614) 722-4458

Location Information for Patients

Main Campus

Biography

William J. Barson, MD, is Chief of the Section of Infectious Diseases and Director of the Infectious Diseases Fellowship Program at Nationwide Children’s Hospital, and Professor Emeritus of Pediatrics at The Ohio State University College of Medicine. Additionally, he serves as the Chair of Nationwide Children’s Hospital’s Pharmacy and Therapeutics Committee.

His clinical interests include the diagnosis and management of infants, children and adolescents with infectious diseases. His research interests are primarily associated with the multi-center surveillance study of Streptococcus pneumoniae infections in children, and he is the local Principal Investigator of the U.S. Pediatric Multicenter Pneumococcal Surveillance Study Group. He has also been involved with a number of antibiotic efficacy and safety studies.

Gender:

  • Male

Languages Spoken:

  • English

Clinical Interests

  • Diagnosis and management of infants, children and adolescents with infectious diseases

Research Interests

Research Center:

Areas of Interest:

  • Infections due to Streptococcus pneumoniae as local principal investigator of the US Pediatric Multicenter Pneumooccal Surveillance Study Group

Education and Training

Medical School

  • Ohio State University
    Date Completed: 06/30/1975

Internship

  • Nationwide Children's Hospital
    Date Completed: 06/30/1976

Residency

  • Nationwide Children's Hospital
    Date Completed: 06/30/1978

Fellowship

  • Nationwide Children's Hospital
    Date Completed: 06/30/1980

Department:

  • Pediatrics

Section:

  • Infectious Diseases

Specialty:

  • Pediatric Infectious Diseases
  • Pediatrics

Date of Appointment at Nationwide Children’s Hospital:

  • 07/01/1980

Publications

  • 2013. Early trends for invasive pneumococcal infections in children after the introduction of the 13-valent pneumococcal conjugate vaccine.
  • 2012. Klebsiella and Raoultella Species. In Principles and Practice of Pediatric Infectious Diseases: Fourth Edition.
  • 2012. Proteus, Providencia, and Morganella Species. In Principles and Practice of Pediatric Infectious Diseases: Fourth Edition.
  • William J. Barson and Mario J. Marcon. 2012. Klebsiella and Raoultella Species. In Principles and Practices of Pediatric Infectious Diseases. Fourth ed. Edited by Sarah Long, Larry Pickering, Charles Prober.
  • William J. Barson and Mario J. Marcon. 2012. Proteus, Providencia, and Morganella Species. In Principles and Practice of Pediatric Infectious Diseases. Fourth ed. Edited by Sarah Long, Larry Pickering, Charles Prober. New York: Elsevier Inc..
  • William J. Barson and Mario J. Marcon. 2012. Proteus, Providencia, and Morganella Species. In Principles and Practice of Pediatric Infectious Diseases. Fourth ed. Edited by Sarah Long, Larry Pickering, Charles Prober.
  • William J. Barson and Mario J. Marcon. 2012. Klebsiella and Raoultella Species. In Principles and Practices of Pediatric Infectious Diseases. Fourth ed. Edited by Sarah Long, Larry Pickering, Charles Prober. New York: Elsevier Inc..
  • 2011. Increase in prevalence of Streptococcus pneumoniae serotype 6C at Eight Children's Hospitals in the United States from 1993 to 2009.  J Clin Microbiol. Vol. 49, no. 6. (June 1).
  • Green MC, Mason EO, Kaplan SL, et al. 2011. Increase of Streptococcus pneumoniae serotyep 6C at 8 children's hospitals in the United States from 1993-2009.  Journal of Clinical Microbiology. Vol. 49, no. January: e2097.
  • 2010. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.  Pediatrics. Vol. 125, no. 3. (March 1).
  • Kaplan SL; Barson WJ; Lin PL; Stovall SH; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Mason EO Jr. 2010. Serotype 19A Is the most common serotype causing invasive pneumococcal infections in children.  Pediatrics. Vol. 125, no. 3. (March): e429.
  • Gill K, Zachary B, Williams C, Raffel C, Bouei D, Barson WJ. 2010. Recurrent meningitis in a teenager.  Pediatr Infect Dis J. Vol. 29, no. January 1: 984-989-984-989.
  • Gill K, Zachary B, Williams C, Raffel C, Bouei D, Barson WJ. 2010. Recurrent meningitis in a teenager.  Pediatr Infect Dis J. Vol. 29, no. January: 984-989.
  • Bolton M, Barson WJ. 2010. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.  Pediatric Ann. Vol. 39, no. January 1: 497-503-497-503.
  • Bolton M, Barson WJ. 2010. Invasive pneumococcal disease and the need for the new 13-valent pneumococcal vaccine.  Pediatric Ann. Vol. 39, no. January: 497-503.
  • 2008. Serious neurologic sequelae in cases of meningitis arising from infection by conjugate vaccine-related and nonvaccine-related serogroups of Streptococcus pneumoniae.  PEDIATRIC INFECTIOUS DISEASE JOURNAL. Vol. 27, no. 9. (September 1).
  • Rajasingham CR, Bonsu BK, Chapman JI, Cohen DM, Barson WJ. 2008. Serious neurologic sequelae in cases of meningitis arising from infection by conjugate vaccine-related and nonvaccine-related serogroups of Streptococcus pneumoniae.  Pediatr Infect Dis J. Vol. 27, no. 9. (September): 771-775.
  • Barson WJ, Marcon MJ. 2008. Klebsiella and Raoultella Species. In Principles and Practices of Pediatric Infectious Diseases, Third Edition. Edited by Long SS, Pickering LK and Prober CG. St. Louis, MO: Churchill Livingstone/Elsevier.
  • Baron WJ, Marcon MJ. 2008. Proteus, Providencia, and Morganella Species. In Principles and Practices of Pediatric Infectious Diseases, Third Edition. Edited by Long SS, Pickering LK and Prober CH. St. Louis, MO: Churchill Livingstone/Elsevier.
  • 2007. Recurrent systemic pneumococcal disease in children.  Pediatr Infect Dis J. Vol. 26, no. 6. (June 1).
  • Mason EO Jr; Wald ER; Tan TQ; Schutze GE; Bradley JS; Barson WJ; Givner LB; Hoffman J; Kaplan SL. 2007. Recurrent systemic pneumococcal disease in children.  The Pediatric Infectious Disease Journal. Vol. 26, no. 6. (June): e480.
  • 2006. Multicenter surveillance of invasive meningococcal infections in children.  Pediatrics. Vol. 118, no. 4. (October 1).
  • Kaplan SL; Schutze GE; Leake JA; Barson WJ; Halasa NB; Byington CL; Woods CR; Tan TQ; Hoffman JA; Wald ER; Edwards KM; Mason EO Jr. 2006. Multicenter surveillance of invasive meningococcal infections in children.  Pediatrics. Vol. 118, no. 4. (October): ee979.
  • Freeman AF, Davis J, Anderson VL, Barson W, et al. 2006. Pneumocystis jiroveci infection in pateints with hyper-immunoglobulin E syndrome.  Pediatrics. Vol. 118, no. January 1: e1271-e1275-e1271-e1275.
  • Freeman AF, Davis J, Anderson VL, Barson W, et al. 2006. Pneumocystis jiroveci infection in pateints with hyper-immunoglobulin E syndrome.  Pediatrics. Vol. 118, no. January: e1271-e1275.
  • 2005. Meningitis in a young infant.  PEDIATRIC INFECTIOUS DISEASE JOURNAL. Vol. 24, no. 4. (April 1).
  • Koranyi KI; Barson WJ; Studley JK. 2005. Meningitis in a young infant.  The Pediatric Infectious Disease Journal. Vol. 24, no. 4. (April): e387.
  • 2004. Pneumococcal endocarditis in children.  Clin Infect Dis. Vol. 38, no. 9. (May 1).
  • Givner LB; Mason EO Jr; Tan TQ; Barson WJ; Schutze GE; Wald ER; Bradley JS; Hoffman J; Yogev R; Kaplan SL. 2004. Pneumococcal endocarditis in children.  Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America. Vol. 38, no. 9. (May): e1273.
  • Kaplan SL; Mason EO Jr; Wald ER; Schutze GE; Bradley JS; Tan TQ; Hoffman JA; Givner LB; Yogev R; Barson WJ. 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.  Pediatrics. Vol. 113, no. 3 Pt 1. (March): e443.
  • 2004. Decrease of invasive pneumococcal infections in children among 8 children's hospitals in the United States after the introduction of the 7-valent pneumococcal conjugate vaccine.  Pediatrics. Vol. 113, no. 3 Pt 1. (March 1).
  • Gonzalez BE, Hulten KG, Kaplan SL, et al. 2004. Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States.  Journal of Clinical Microbiology. Vol. 42, no. January: 2810-2812.
  • Gonzalez BE, Hulten KG, Kaplan SL, et al. 2004. Clonality of Streptococcus pneumoniae serotype 1 isolates from pediatric patients in the United States.  Journal of Clinical Microbiology. Vol. 42, no. January 1: 2810-2812-2810-2812.
  • Hoffman JA; Mason EO; Schutze GE; Tan TQ; Barson WJ; Givner LB; Wald ER; Bradley JS; Yogev R; Kaplan SL. 2003. Streptococcus pneumoniae infections in the neonate.  Pediatrics. Vol. 112, no. 5. (November): e1095.
  • 2003. Streptococcus pneumoniae infections in the neonate.  Pediatrics. Vol. 112, no. 5. (November 1).
  • 2003. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.  Pediatr Infect Dis J. Vol. 22, no. 7. (July 1).
  • Mason EO Jr; Wald ER; Bradley JS; Barson WJ; Kaplan SL. 2003. Macrolide resistance among middle ear isolates of Streptococcus pneumoniae observed at eight United States pediatric centers: prevalence of M and MLSB phenotypes.  The Pediatric Infectious Disease Journal. Vol. 22, no. 7. (July): e623.
  • 2003. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.  Antimicrob Agents Chemother. Vol. 47, no. 1. (January 1).
  • Mason EO Jr; Lamberth LB; Wald ER; Bradley JS; Barson WJ; Kaplan SL. 2003. In vitro activities of cethromycin (ABT-773), a new ketolide, against Streptococcus pneumoniae strains that are not susceptible to penicillin or macrolides.  Antimicrobial Agents And Chemotherapy. Vol. 47, no. 1. (January): e166.
  • 2002. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.  Pediatrics. Vol. 110, no. 1 Pt 1. (July 1).
  • Tan TQ; Mason EO Jr; Wald ER; Barson WJ; Schutze GE; Bradley JS; Givner LB; Yogev R; Kim KS; Kaplan SL. 2002. Clinical characteristics of children with complicated pneumonia caused by Streptococcus pneumoniae.  Pediatrics. Vol. 110, no. 1 Pt 1. (July): e1.
  • 2002. Invasive pneumococcal infections in children with asplenia.  Pediatr Infect Dis J. Vol. 21, no. 4. (April 1).
  • Schutze GE; Mason EO Jr; Barson WJ; Kim KS; Wald ER; Givner LB; Tan TQ; Bradley JS; Yogev R; Kaplan SL. 2002. Invasive pneumococcal infections in children with asplenia.  The Pediatric Infectious Disease Journal. Vol. 21, no. 4. (April): e278.
  • 2002. Six year multicenter surveillance of invasive pneumococcal infections in children.  Pediatr Infect Dis J. Vol. 21, no. 2. (February 1).
  • Kaplan SL; Mason EO Jr; Wald E; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Barson WJ. 2002. Six year multicenter surveillance of invasive pneumococcal infections in children.  The Pediatric Infectious Disease Journal. Vol. 21, no. 2. (February): e141.
  • Schutze GE; Mason EO Jr; Wald ER; Barson WJ; Bradley JS; Tan TQ; Kim KS; Givner LB; Yogev R; Kaplan SL. 2001. Pneumococcal infections in children after transplantation.  Clinical Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of America. Vol. 33, no. 1. (July): e16.
  • 2001. Pneumococcal infections in children after transplantation.  Clin Infect Dis. Vol. 33, no. 1. (July 1).
  • Kaplan SL; Mason EO Jr; Barson WJ; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R; Wald ER. 2001. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.  The Pediatric Infectious Disease Journal. Vol. 20, no. 4. (April): e392.
  • 2001. Outcome of invasive infections outside the central nervous system caused by Streptococcus pneumoniae isolates nonsusceptible to ceftriazone in children treated with beta-lactam antibiotics.  Pediatr Infect Dis J. Vol. 20, no. 4. (April 1).
  • Wald ER; Mason EO Jr; Bradley JS; Barson WJ; Kaplan SL. 2001. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997.  The Pediatric Infectious Disease Journal. Vol. 20, no. 1. (January): e34.
  • 2001. Acute otitis media caused by Streptococcus pneumoniae in children's hospitals between 1994 and 1997.  Pediatr Infect Dis J. Vol. 20, no. 1. (January 1).
  • 2000. Pneumococcal facial cellulitis in children.  Pediatrics. Vol. 106, no. 5. (November 1).
  • Givner LB; Mason EO Jr; Barson WJ; Tan TQ; Wald ER; Schutze GE; Kim KS; Bradley JS; Yogev R; Kaplan SL. 2000. Pneumococcal facial cellulitis in children.  Pediatrics. Vol. 106, no. 5. (November): eE61.
  • Kaplan SL; Mason EO Jr; Wald ER; Kim KS; Givner LB; Bradley JS; Barson WJ; Tan TQ; Schutze GE; Yogev R. 2000. Pneumococcal mastoiditis in children.  Pediatrics. Vol. 106, no. 4. (October): e695.
  • 2000. Pneumococcal mastoiditis in children.  Pediatrics. Vol. 106, no. 4. (October 1).
  • Azimi PH; Barson WJ; Janner D; Swanson R. 1999. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.  The Pediatric Infectious Disease Journal. Vol. 18, no. 7. (July): e609.
  • 1999. Efficacy and safety of ampicillin/sulbactam and cefuroxime in the treatment of serious skin and skin structure infections in pediatric patients. UNASYN Pediatric Study Group.  Pediatr Infect Dis J. Vol. 18, no. 7. (July 1).
  • Bradley JS; Kaplan SL; Tan TQ; Barson WJ; Arditi M; Schutze GE; Wald ER; Givner LB; Mason EO. 1998. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG).  Pediatrics. Vol. 102, no. 6. (December): e1376.
  • Tan TQ; Mason EO Jr; Barson WJ; Wald ER; Schutze GE; Bradley JS; Arditi M; Givner LB; Yogev R; Kim KS; Kaplan SL. 1998. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.  Pediatrics. Vol. 102, no. 6. (December): e1369.
  • 1998. Pediatric pneumococcal bone and joint infections. The Pediatric Multicenter Pneumococcal Surveillance Study Group (PMPSSG).  Pediatrics. Vol. 102, no. 6. (December 1).
  • 1998. Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.  Pediatrics. Vol. 102, no. 6. (December 1).
  • 1998. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.  Pediatrics. Vol. 102, no. 5. (November 1).
  • Arditi M; Mason EO Jr; Bradley JS; Tan TQ; Barson WJ; Schutze GE; Wald ER; Givner LB; Kim KS; Yogev R; Kaplan SL. 1998. Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.  Pediatrics. Vol. 102, no. 5. (November): e1087.
  • 1998. Three-year multicenter surveillance of systemic pneumococcal infections in children.  Pediatrics. Vol. 102, no. 3 Pt 1. (September 1).
  • Barson WJ. 1998. Probable actinic Rocky Mountain spotted fever.  The Pediatric Infectious Disease Journal. Vol. 17, no. 9. (September): e850.
  • Kaplan SL; Mason EO Jr; Barson WJ; Wald ER; Arditi M; Tan TQ; Schutze GE; Bradley JS; Givner LB; Kim KS; Yogev R. 1998. Three-year multicenter surveillance of systemic pneumococcal infections in children.  Pediatrics. Vol. 102, no. 3 Pt 1. (September): e538.
  • 1998. Probable actinic Rocky Mountain spotted fever.  Pediatr Infect Dis J. Vol. 17, no. 9. (September 1).
  • Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ. 1997. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.  Chest. Vol. 112, no. 5. (November 1): 1208-1208.
  • Bates RD; Nahata MC; Jones JW; McCoy K; Young G; Cox S; Barson WJ. 1997. Pharmacokinetics and safety of tobramycin after once-daily administration in patients with cystic fibrosis.  Chest. Vol. 112, no. 5. (November): e1208.
  • Sferra TJ; Barson WJ. 1997. Escherichia coli arthritis as the presenting manifestation of posterior urethral valves.  The Pediatric Infectious Disease Journal. Vol. 16, no. 2. (February): e260.
  • 1997. Escherichia coli arthritis as the presenting manifestation of posterior urethral valves.  Pediatr Infect Dis J. Vol. 16, no. 2. (February 1).
  • Shaffer JP, Allen E, Groner JI, Barson W, Lequette M, Hogan MJ. 1997. Massive hemoptysis as the presenting manifestation in a child with histoplasmosis.  Pediatric Pulmonology. Vol. 24, no. January: 57-60.
  • Shaffer JP, Allen E, Groner JI, Barson W, Lequette M, Hogan MJ. 1997. Massive hemoptysis as the presenting manifestation in a child with histoplasmosis.  Pediatric Pulmonology. Vol. 24, no. January 1: 57-60-57-60.
  • 1996. Successful therapy of Candida albicans arthritis with a sequential intravenous amphotericin B and oral fluconazole regimen.  PEDIATRIC INFECTIOUS DISEASE JOURNAL. Vol. 15, no. 12. (December 1).
  • Barson WJ; Marcon MJ. 1996. Successful therapy of Candida albicans arthritis with a sequential intravenous amphotericin B and oral fluconazole regimen.  The Pediatric Infectious Disease Journal. Vol. 15, no. 12. (December): e1119.
  • 1996. Malignant external otitis as the presentation of childhood acute lymphocytic leukemia.  Pediatr Infect Dis J. Vol. 15, no. 12. (December 1).
  • Pacini DL; Trevorrow T; Rao MK; Birck HG; Barson WJ. 1996. Malignant external otitis as the presentation of childhood acute lymphocytic leukemia.  The Pediatric Infectious Disease Journal. Vol. 15, no. 12. (December): e1132.
  • 1995. Pharmacokinetics of cefpirome in pediatric patients.  Antimicrob Agents Chemother. Vol. 39, no. 10. (October 1).
  • Nahata MC; Barson WJ; Puri SK. 1995. Pharmacokinetics of cefpirome in pediatric patients.  Antimicrobial Agents And Chemotherapy. Vol. 39, no. 10. (October): e2348.
  • Wald ER, Kaplan SL, Mason EO, Sado D, Russ L, Arditi M, Wiederman BL, Barson W, Kim KS, Yogev R, Hofkosh D. 1995. Dexamethasone therapy for children with bacterial meningitis.  Pediatrics. Vol. 95, no. January: 21-28.
  • Chattoraj MR, Barson W, McClead RE. 1994. Neonatal osteomyelitis. Radiological Case of the Month.  Archives of Pediatric and Adolescent Medicine. Vol. 148, no. January 1: 1305-1306-1305-1306.
  • Chattoraj MR, Barson W, McClead RE. 1994. Neonatal osteomyelitis. Radiological Case of the Month.  Archives of Pediatric and Adolescent Medicine. Vol. 148, no. January: 1305-1306.
  • 1993. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.  Chemotherapy. Vol. 39, no. 1. (January 1).
  • Nahata MC; Kohlbrenner VM; Barson WJ. 1993. Pharmacokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children.  Chemotherapy. Vol. 39, no. 1. (January): e1.
  • Spearman PW; Barson WJ. 1992. Toxic shock syndrome occurring in children with abrasive injuries beneath casts.  Journal Of Pediatric Orthopedics. Vol. 12, no. 2. (March): e169.
  • 1992. Toxic shock syndrome occurring in children with abrasive injuries beneath casts.  J Pediatr Orthop. Vol. 12, no. 2. (March 1).
  • 1991. Group A streptococcal toxic shock-like syndrome.  Pediatr Infect Dis J. Vol. 10, no. 12. (December 1).
  • Barson WJ. 1991. Group A streptococcal toxic shock-like syndrome.  The Pediatric Infectious Disease Journal. Vol. 10, no. 12. (December): e958.
  • 1990. STAPHYLOCOCCUS-AUREUS OSTEOMYELITIS ASSOCIATED WITH VARICELLA INFECTION.  PEDIATRIC INFECTIOUS DISEASE JOURNAL. Vol. 9, no. 2. (February 1).
  • Barson WJ; Fortney JL. 1990. Staphylococcus aureus osteomyelitis associated with varicella infection.  The Pediatric Infectious Disease Journal. Vol. 9, no. 2. (February): e146.
  • Nahata MC; Fan-Havard P; Barson WJ; Bartkowski HM; Kosnik EJ. 1990. Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.  European Journal Of Clinical Pharmacology. Vol. 38, no. 5. (January): e515.
  • Fan-Havard P; Nahata MC; Bartkowski MH; Barson WJ; Kosnik EJ. 1990. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement.  Chemotherapy. Vol. 36, no. 2. (January): e103.
  • Nahata MC, Durrell DE, Barson WJ. 1990. Pharmocokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children with bacterial meningitis.  Pharmacotherapy. Vol. 10, no. January: 238-242.
  • Nahata MC; Fan-Havard P; Kosnik EJ; Bartkowski MH; Barson WJ. 1990. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.  Chemotherapy. Vol. 36, no. 2. (January): e98.
  • 1990. Pharmacokinetics and cerebrospinal fluid concentration of nafcillin in pediatric patients undergoing cerebrospinal fluid shunt placement.  Chemotherapy. Vol. 36, no. 2. (January 1).
  • 1990. Pharmacokinetics, cerebrospinal fluid concentration, and safety of intravenous rifampin in pediatric patients undergoing shunt placements.  Eur J Clin Pharmacol. Vol. 38, no. 5. (January 1).
  • Nahata MC, Durrell DE, Barson WJ. 1990. Pharmocokinetics and cerebrospinal fluid concentrations of cefixime in infants and young children with bacterial meningitis.  Pharmacotherapy. Vol. 10, no. January 1: 238-242-238-242.
  • 1990. Pharmacokinetics and cerebrospinal fluid (CSF) concentrations of vancomycin in pediatric patients undergoing CSF shunt placement.  Chemotherapy. Vol. 36, no. 2. (January 1).
  • Barson WJ. 1989. Treatment of Bacillus infections.  Pediatrics. Vol. 84, no. 2. (August): e403.
  • 1989. Treatment of Bacillus infections.  Pediatrics. Vol. 84, no. 2. (August 1).
  • 1989. Dexamethasone therapy for bacterial meningitis.  New England Journal of Medicine. Vol. 320, no. 7. (January 1).
  • 1988. Histamine-like reaction after a single intravenous dose of rifampin.  Clin Pharm. Vol. 7, no. 8. (August 1).
  • Fan-Havard P; Nahata MC; Barson WJ; Bartkowski H; Kosnik E. 1988. Histamine-like reaction after a single intravenous dose of rifampin.  Clinical Pharmacy. Vol. 7, no. 8. (August): e616.
  • 1988. Acute scrotum due to Haemophilus influenzae type b.  J Pediatr Surg. Vol. 23, no. 2. (February 1).
  • Lin YC; King DR; Birken GA; Barson WJ. 1988. Acute scrotum due to Haemophilus influenzae type b.  Journal Of Pediatric Surgery. Vol. 23, no. 2. (February): e183.
  • Barson WJ; Brady MT. 1987. Management of infections in children with cancer.  Hematology/Oncology Clinics Of North America. Vol. 1, no. 4. (December): e801.
  • Barson WJ; Brady MT. 1987. Management of infections in children with cancer.  Hematology/Oncology Clinics Of North America. Vol. 1, no. 4. (December 1): 801-801.
  • 1987. PUNCTURE WOUND OSTEOCHONDRITIS OF THE FOOT CAUSED BY CDC GROUP VD.  JOURNAL OF CLINICAL MICROBIOLOGY. Vol. 25, no. 10. (October 1).
  • Barson WJ; Cromer BA; Marcon MJ. 1987. Puncture wound osteochondritis of the foot caused by CDC group Vd.  Journal Of Clinical Microbiology. Vol. 25, no. 10. (October): e2014.
  • Brady MT; Barson WJ; Cannon HJ Jr; Grossman LK. 1987. Onset of Hemophilus influenzae type-b meningitis during cefaclor therapy for preseptal cellulitis.  Clinical Pediatrics. Vol. 26, no. 3. (March): e132.
  • 1987. ONSET OF HAEMOPHILUS-INFLUENZAE TYPE-B MENINGITIS DURING CEFACLOR THERAPY FOR PRESEPTAL CELLULITIS.  CLINICAL PEDIATRICS. Vol. 26, no. 3. (March 1).
  • Barson WJ; Reiner CB. 1986. Coxsackievirus B2 infection in a neonate with incontinentia pigmenti.  Pediatrics. Vol. 77, no. 6. (June): e897.
  • 1986. Coxsackievirus B2 infection in a neonate with incontinentia pigmenti.  Pediatrics. Vol. 77, no. 6. (June 1).
  • Barson WJ. 1986. Anterior uveitis associated with septic staphylococcal scarlet fever.  Pediatric Infectious Disease. Vol. 5, no. 3. (May): e385.
  • Barson WJ. 1986. Group C streptococcal osteomyelitis.  Journal Of Pediatric Orthopedics. Vol. 6, no. 3. (May): e346.
  • 1986. Anterior uveitis associated with septic staphylococcal scarlet fever.  Pediatr Infect Dis. Vol. 5, no. 3. (May 1).
  • 1986. Group C streptococcal osteomyelitis.  J Pediatr Orthop. Vol. 6, no. 3. (May 1).
  • 1986. Palmar aspergillosis in immunocompromised children.  Pediatr Infect Dis. Vol. 5, no. 2. (March 1).
  • Barson WJ; Ruymann FB. 1986. Palmar aspergillosis in immunocompromised children.  Pediatric Infectious Disease. Vol. 5, no. 2. (March): e264.
  • Barson WJ. 1986. Branhamella catarrhalis scalp absces complicating intrapartum monitoring.  Clinical Pediatrics. Vol. 25, no. January 1: 394-394-394-394.
  • Nahata MC; Durrell DE; Barson WJ. 1986. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.  Chemotherapy. Vol. 32, no. 2. (January): e89.
  • Barson WJ. 1986. Branhamella catarrhalis scalp absces complicating intrapartum monitoring.  Clinical Pediatrics. Vol. 25, no. January: 394-394.
  • 1986. Ceftriaxone kinetics and cerebrospinal fluid penetration in infants and children with meningitis.  Chemotherapy. Vol. 32, no. 2. (January 1).
  • Nahata MC; Barson WJ. 1985. Ceftriaxone: a third-generation cephalosporin.  Drug Intelligence & Clinical Pharmacy. Vol. 19, no. 12. (December): e900.
  • 1985. Ceftriaxone: a third-generation cephalosporin.  Drug Intell Clin Pharm. Vol. 19, no. 12. (December 1).
  • Barson WJ; Miller MA; Marcon MJ; Hribar MM; Brady MT; Pacini DL; Powell DA. 1985. Cefuroxime therapy for bacteremic soft-tissue infections in children.  American Journal Of Diseases Of Children (1960). Vol. 139, no. 11. (November): e1141.
  • Barson WJ; Miller MA; Brady MT; Powell DA. 1985. Prospective comparative trial of ceftriaxone vs. conventional therapy for treatment of bacterial meningitis in children.  Pediatric Infectious Disease. Vol. 4, no. 4. (July): e362.
  • 1985. Granuloma and pseudogranuloma of the skin due to Microsporum canis. Successful management with local injections of miconazole.  Arch Dermatol. Vol. 121, no. 7. (July 1).
  • Barson WJ. 1985. Granuloma and pseudogranuloma of the skin due to Microsporum canis. Successful management with local injections of miconazole.  Archives Of Dermatology. Vol. 121, no. 7. (July): e895.
  • 1985. CEFUROXIME THERAPY FOR BACTEREMIC SOFT-TISSUE INFECTIONS IN CHILDREN.  AMERICAN JOURNAL OF DISEASES OF CHILDREN. Vol. 139, no. 11. (January 1).
  • 1985. PROSPECTIVE COMPARATIVE TRIAL OF CEFTRIAXONE VS CONVENTIONAL THERAPY FOR TREATMENT OF BACTERIAL-MENINGITIS IN CHILDREN.  PEDIATRIC INFECTIOUS DISEASE JOURNAL. Vol. 4, no. 4. (January 1).
  • Furman WL; Menke JA; Barson WJ; Miller RR. 1984. Continuous naloxone infusion in two neonates with septic shock.  The Journal Of Pediatrics. Vol. 105, no. 4. (October): e649.
  • Furman WL; Menke JA; Barson WJ; Miller RR. 1984. Continuous naloxone infusion in two neonates with septic shock.  The Journal Of Pediatrics. Vol. 105, no. 4. (October 1): 649-649.
  • Westman JA; Barson WJ; Powell DA. 1984. Dactylitis and tuberculid eruptions in a child with primary tuberculosis.  Pediatric Infectious Disease. Vol. 3, no. 3. (May): e251.
  • Barson WJ; Miller MA. 1984. Relapse of Haemophilus influenzae type b meningitis following therapy with ceftriaxone.  Pediatric Infectious Disease. Vol. 3, no. 3. (May): e241.
  • Westman JA; Barson WJ; Powell DA. 1984. Dactylitis and tuberculid eruptions in a child with primary tuberculosis.  Pediatric Infectious Disease. Vol. 3, no. 3. (May 1): 251-251.
  • 1984. Relapse of haemophilus influenzae type b meningitis following therapy with ceftriaxone.  Pediatric Infectious Disease. Vol. 3, no. 3. (January 1).
  • Nahata MC; Powell DA; Glazer JP; Barson WJ. 1982. Teaching pediatric infectious diseases to medical, pharmacy, and nursing students during monthly rotations.  Journal Of Medical Education. Vol. 57, no. 8. (August): e640.
  • Nahata MC; Durrell DE; Barson WJ. 1982. Moxalactam epimer kinetics in children.  Clinical Pharmacology And Therapeutics. Vol. 31, no. 4. (April): e528.
  • 1982. Moxalactam epimer kinetics in children.  Clin Pharmacol Ther. Vol. 31, no. 4. (April 1).
  • 1982. Moxalactam in pediatrics.  Drug Intell Clin Pharm. Vol. 16, no. 2. (February 1).
  • Barson WJ; Nahata MC. 1982. Moxalactam in pediatrics.  Drug Intelligence & Clinical Pharmacy. Vol. 16, no. 2. (February): e113.
  • 1982. TEACHING PEDIATRIC INFECTIOUS-DISEASES TO MEDICAL, PHARMACY, AND NURSING-STUDENTS DURING MONTHLY ROTATIONS.  JOURNAL OF MEDICAL EDUCATION. Vol. 57, no. 8. (January 1).
  • Barson WJ; Craenen J; Hosier DM; Brawley RL; Hilty MD. 1981. Survival following myocarditis and myocardial calcification associated with infection by Coxsackie virus B-4.  Pediatrics. Vol. 68, no. 1. (July): e79.
  • 1981. Survival following myocarditis and myocardial calcification associated with infection by Coxsackie virus B-4.  Pediatrics. Vol. 68, no. 1. (July 1).
  • 1980. Acute septic arthritis caused by Neisseria meningitidis serogroup W-135.  South Med J. Vol. 73, no. 3. (March 1).
  • Brawley RL; Barson WJ; Palmer R; Hilty MD; Koranyi K. 1980. Acute septic arthritis caused by Neisseria meningitidis serogroup W-135.  Southern Medical Journal. Vol. 73, no. 3. (March): e395.
  • Pietropaolo D, Magee M, Kneiper R, et al. 0. Should all young febrile infants 60 days of age or younger be tested for enterovirus in CSF by PCR?. In Pediatric Academic Societies Annual Meeting
  • Kaplan SL, Barson WJ, Lin P, et al. 0. Early trends for invasive pneumococcal infections in children following the introduction of the 13-valent pneumococcal conjugate vaccine. In IDSA
  • Pietropaolo D, Magee M, Kneiper R, et al. Should all young febrile infants 60 days of age or younger be tested for enterovirus in CSF by PCR?. In Pediatric Academic Societies Annual Meeting
  • Mason EO Jr, Wald ER, Tan TQ, Schutze GE, Bradley JS, Barson WJ, Givner LB, Hoffman J, Kaplan SL. Recurrent systemic pneumococcal disease in children. The Pediatric Infectious Disease Journal 26(6): 480-484, 2007.

Awards, Honors and Organizations

  • Courage to Teach Honorary of The Ohio State University College of Medicine - 2015
  • Infectious Diseases Society of America (Fellow)
  • Excellence in Teaching Award, Department of Pediatrics, College of Medicine and Public Health, The Ohio State University - 2003
  • Central Ohio Pediatric Society
  • The Grant Morrow III Teaching Award, presented by Pediatric House Staff of Nationwide Children's Hospital for Outstanding Teaching and Practice of Pediatrics - 2009
  • The OSU College of Medicine Distinguished Educator Award, presented by the OSU College of Medicine in recognition of distinguished service to the tradition of excellence in undergraduate medical education - 2014
  • Pediatrician of the Year Award, Presented by House Staff, Children's Hospital for Outstanding Teaching and Practice of Pediatrics, Columbus, Ohio - 1984
  • Pediatric Infectious Diseases Society (Fellow)
  • American Academy of Family Physicians Teaching Recognition Award for participation as an Active Teacher in Family Practice - 1984
  • American Academy of Pediatrics (Fellow)
  • Listed, Best Doctors in America
Nationwide Children's Hospital
700 Children's Drive Columbus, Ohio 43205 614.722.2000